Altoida is differentiated by its AR-based multimodal cognitive assessment capturing 600+ biomarkers in a 10-minute session, giving it a broader signal surface than most digital cognitive screening tools. The platform sits in the investigational segment for MCI and Alzheimer's detection, with validation across 42,000+ tests but no regulatory clearance for diagnostic use.